AI Article Synopsis
- A 31-year-old Thai male with a 6-year history of HIV developed severe anemia after one month of Highly Active Anti Retroviral Therapy (HAART), despite no opportunistic infections.
- Investigations revealed he had pure red cell aplasia, likely due to parvovirus B19, confirmed by detecting the virus's DNA in his blood.
- He received blood transfusions for treatment while continuing HAART, highlighting the need to consider parvovirus B19 as a potential cause of anemia in HIV patients.
Article Abstract
Anemia in HIV-infected patients is a common clinical manifestation. We report on a 31-year-old Thai male, who had been HIV positive for 6 years, did not harbor any opportunistic infection, and had been receiving Highly Active Anti Retroviral Therapy (HAART) for one month, and who developed severe anemia. Investigation revealed pure red cell aplasia, suspected secondary to parvovirus B19 infection. This diagnosis was confirmed by the detection of parvovirus B19 DNA in his serum. He received blood transfusions for supportive treatment and continued on HAART to improve his immune status and to resolve the anemia. This case suggests that parvovirus B19 infection should be considered as a possible cause of anemia in HIV-infected individuals.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!